Drawing for LUMIPORE

USPTO serial 79366928

LUMIPORE

Reviewed by CopyMark Law Group

Reg. 7554064Status 700Registered
Filing date
Status date
Registration date
Nov 5, 2024
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LUMIPORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clifford D Hyra

Clifford D Hyra Fresh IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments for cell modification, namely, transfection devices; scientific apparatus and instruments for scientific research and development, namely, transfection devices for cell modification; scientific apparatus and instruments for scientific research and development, namely, devices for transfection of cells for clinical research and medical research; Scientific apparatus and instruments for use in cell therapy, stem cell therapy, tissue engineering and regenerative medicine, namely, devices for the ablation and killing of cells; laboratory instruments for use in immunotherapy and cancer treatment, namely, transfection devices; laboratory instruments for use in tissue engineering and regenerative medicine, namely, devices for transfection, cell and tissue ablation and cell killing; laboratory instruments for the development of gene modified cell therapies, namely, transfection devices; laboratory equipment for modification of cells for research related to the treatment of diseases, namely, devices for transfection, cell ablation and cell killing; equipment for cell manipulation, namely, devices for transfection, cell ablation and cell killingACTIVE—
010Medical devices, namely, transfection devices used for cell therapy treatments; Medical devices, namely, instruments used for immunotherapy treatments and for modifying cells for the treatment of cancer and other diseases and medical conditions related to tissue engineering and regenerative medicine namely, devices for transfection, cell ablation and cell killing; apparatus for the regeneration of stem cells and tissues for medical purpose; medical apparatus and instruments for use in cell therapy, stem cell therapy, tissue engineering and regenerative medicine, namely, devices for transfection, cell ablation and cell killing; unfilled cartridges for cell transfection, cell ablation and cell killing for medical diagnostic purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 26, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 7, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 7, 2025FIMPFINAL DISPOSITION PROCESSED—
Feb 5, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 5, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 5, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 20, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 4, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 4, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 20, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 20, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 31, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 12, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 9, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 1, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 1, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 1, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 2, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 2, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 21, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 12, 2023RFNTREFUSAL PROCESSED BY IB—
Nov 21, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 21, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 18, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 17, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2023DOCKASSIGNED TO EXAMINER—
Jun 4, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 14, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 6, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance